ANCA-positive crescentic glomerulonephritis in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor alpha

被引：6
|
作者：
Alkhunaizi, Ahmed M. [1 ]
Dawamneh, Mohamad F. [2 ]
机构：
[1] Johns Hopkins Aramco Healthcare, Internal Med Serv Div, Nephrol Sect, Dhahran, Saudi Arabia
[2] Johns Hopkins Aramco Healthcare, Div Pathol, Dhahran, Saudi Arabia
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2017年 / 20卷 / 11期
关键词：
HENOCH-SCHONLEIN PURPURA; RECEIVING TREATMENT; RENAL VASCULITIS; ETANERCEPT; THERAPY;
D O I：
10.1111/1756-185X.12612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1843 / 1847
页数：5
相关论文
共 50 条
  • [41] Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report
    Selim Nalbant
    Mustafa Özyurt
    Murat Yıldırım
    Mesih Kuskucu
    [J]. Rheumatology International, 2012, 32 : 2863 - 2866
  • [42] Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report
    Nalbant, Selim
    Ozyurt, Mustafa
    Yildirim, Murat
    Kuskucu, Mesih
    [J]. RHEUMATOLOGY INTERNATIONAL, 2012, 32 (09) : 2863 - 2866
  • [43] Appearance of rheumatoid nodules following anti-tumor necrosis factor a treatment with adalimumab for rheumatoid arthritis
    Scrivo, R.
    Spadaro, A.
    Iagnocco, A.
    Valesini, G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : 117 - 117
  • [44] The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis
    Tikiz, Hakan
    Arslan, Oezlem
    Pirildar, Timur
    Tikiz, Canan
    Bayindir, Petek
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (02): : 98 - 103
  • [45] Obesity and Remission Rates in Japanese Patients With Rheumatoid Arthritis Requiring Anti-Tumor Necrosis Factor Alpha Therapy
    Yamazaki, Kenji
    Suzuki, Etsuji
    Ishihara, Ryuhei
    Miyamoto, Toshiaki
    [J]. ARCHIVES OF RHEUMATOLOGY, 2020, 35 (04) : 600 - 608
  • [46] ORAL GLUCOCORTICOID USE IN RITUXIMAB-TREATED RHEUMATOID ARTHRITIS PATIENTS WITH PRIOR EXPOSURE TO ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY
    Johnston, S. S.
    Kamath, T.
    Shi, N.
    Fowler, R.
    Chu, B. C.
    Reiss, W.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A218 - A218
  • [47] Dermatomyositis Induced by Anti-Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis
    Liu, Stephanie W.
    Velez, Nicole F.
    Lam, Christina
    Femia, Alisa
    Granter, Scott R.
    Townsend, Henry B.
    Vleugels, Ruth Ann
    [J]. JAMA DERMATOLOGY, 2013, 149 (10) : 1204 - 1208
  • [48] Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis
    Ulfgren, AK
    Andersson, U
    Engström, M
    Klareskog, L
    Maini, RN
    Taylor, PC
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (11): : 2391 - 2396
  • [49] Anti-tumor necrosis factor-α agents for rheumatoid arthritis:: Assessing longterm safety
    Hyrich, KL
    Silman, AJ
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (05) : 831 - 833
  • [50] Strategies after the failure of the first anti-tumor necrosis factor α agent in rheumatoid arthritis
    Papagoras, Charalampos
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    [J]. AUTOIMMUNITY REVIEWS, 2010, 9 (08) : 574 - 582
12345